Canada House Wellness Group Announces Fulfillment of First Purchase Orders to SQDC

IsoCanMed Inc. begins processing weekly purchase orders in accordance with existing Letter of Intent with SQDC TORONTO, Oct. 7, 2020 /CNW/ – Canada House Wellness Group (CSE: CHV) (“Canada House” or the “Company“), a fully integrated medical cannabis company, is pleased to announce that its wholly owned subsidiary, IsoCanMed Inc. (“ICM“), has fulfilled its first purchase orders under the termsContinue reading “Canada House Wellness Group Announces Fulfillment of First Purchase Orders to SQDC”

Halo Signs Definitive Agreement to Acquire Canmart

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated September 16, 2020 to its short form base shelf prospectus dated September 2, 2020. TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) has entered into a definitive share purchase agreement, (the “ShareContinue reading “Halo Signs Definitive Agreement to Acquire Canmart”

Zenabis Announces Closing of Public Offering of Units

– Zenabis Global Inc. (TSX: ZENA)(“Zenabis” or the “Company“) is pleased to announce the closing of the previously announced overnight marketed offering of units of Zenabis (“Units“), including the exercise in part of the over-allotment option (together, the “Offering“). Pursuant to the Offering, the Company sold 89,317,747 Units at a price of $0.085 per Unit for aggregate grossContinue reading “Zenabis Announces Closing of Public Offering of Units”

VIVO Cannabis™ Completes Debenture Refinancing

 – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“) today announced that it has completed its previously announced partial prepayment, conversion and amendment of unsecured convertible debentures (the “Debentures“). As a result, VIVO now has $6.6 million in outstanding Debentures due September 15, 2022 and 328.7 million common shares (each, a “Share”) outstanding on an undiluted basis. “One ofContinue reading “VIVO Cannabis™ Completes Debenture Refinancing”

WeedMD Enters into Binding Term Sheet for $30 Million Credit Facility with LiUNA Pension Fund and Changes Filing Date of Second Quarter 2020 Financials to September 30, 2020

Non-dilutive financing to fund continued growth including accelerating sales of Color Cannabis adult-use products and Starseed’s unique medical service offerings to payor groups and patients Company financials will now be filed on September 30, 2020 with management-hosted earnings call on October 1, 2020 at 10 a.m. EST — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensedContinue reading “WeedMD Enters into Binding Term Sheet for $30 Million Credit Facility with LiUNA Pension Fund and Changes Filing Date of Second Quarter 2020 Financials to September 30, 2020”

Khiron Declared a National Strategic Project by the Government of Colombia

Status Accelerates Ability to Bring New Products and Services to Market The National Interest Strategic Project certification (“PINES”) was established by the Government of Colombia to prioritize the development of specific projects or companies that are deemed by the Government to be able to significantly increase the national economy Khiron’s PINES certification as a Colombian Pharmaceutical ProducerContinue reading “Khiron Declared a National Strategic Project by the Government of Colombia”

Curaleaf Opens its First Retail Location in Utah with Lehi Pharmacy

— Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, announced the company’s first retail location in the Utah market with a new pharmacy at 3633 N. Thanksgiving Way in Lehi, marking its 90th retail location nationwide. Curaleaf UT, LLC, was awarded one of the state’s 14 licenses in theContinue reading “Curaleaf Opens its First Retail Location in Utah with Lehi Pharmacy”

Organigram Sends First Shipment of Indoor-Grown Dried Flower to Israeli Cannabis Producer, Canndoc Ltd.

–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced that it has sent its first shipment of bulk dried flower to Canndoc Ltd. (“Canndoc”), one of Israel’s largest and most established medical cannabis producers, and a subsidiary of InterCureContinue reading “Organigram Sends First Shipment of Indoor-Grown Dried Flower to Israeli Cannabis Producer, Canndoc Ltd.”

MediPharm Labs Appoints Former President of Janssen Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to Board of Directors

— MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce the appointment of Chris Halyk – former President of Janssen Inc. (Canada), one of the Janssen Pharmaceutical Companies of Johnson & Johnson – to its Board of Directors,Continue reading “MediPharm Labs Appoints Former President of Janssen Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to Board of Directors”